HCWC vs XWEL vs BTMD vs OPRX vs GDRX

For growth investors, Healthy Choice Wellness Corp.

(HCWC) is the stronger pick with 24. 6% revenue growth year-over-year, versus -13. 8% for XWELL, Inc. (XWEL). biote Corp. (BTMD) offers the better valuation at 2. 8x trailing P/E, making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, biote Corp.

(BTMD) is the cheapest at 2. 8x versus GoodRx Holdings, Inc. at 33. 3x. On forward P/E, OptimizeRx Corporation is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, biote Corp.

(BTMD) delivered a total return of -79. 1%, compared to -95. 0% for XWELL, Inc. (XWEL). Over 10 years, the gap is even starker: OPRX returned +110. 5% versus XWEL's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), XWELL, Inc.

(XWEL) is the lower-risk stock at 0. 88β versus OptimizeRx Corporation's 2. 28β — meaning OPRX is approximately 159% more volatile than XWEL relative to the S&P 500. On balance sheet safety, OptimizeRx Corporation (OPRX) carries a lower debt/equity ratio of 4% versus 11% for Healthy Choice Wellness Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Healthy Choice Wellness Corp.

(HCWC) is pulling ahead at 24. 6% versus -13. 8% for XWELL, Inc. (XWEL). On earnings-per-share growth, the picture is similar: biote Corp. grew EPS 703. 5% year-over-year, compared to -38. 8% for XWELL, Inc.. Over a 3-year CAGR, HCWC leads at 83. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

biote Corp.

(BTMD) is the more profitable company, earning 14. 1% net margin versus -58. 2% for XWELL, Inc. — meaning it keeps 14. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTMD leads at 18. 5% versus -32. 0% for XWEL. At the gross margin level — before operating expenses — GDRX leads at 82. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 7.

0x forward P/E versus 9. 0x for GoodRx Holdings, Inc. — 1. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 156. 4% to $17. 00.

In this comparison, XWEL (3.

8% yield), BTMD (2. 3% yield) pay a dividend. HCWC, OPRX, GDRX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, XWELL, Inc.

(XWEL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 88), 3. 8% yield). OptimizeRx Corporation (OPRX) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XWEL: -100. 0%, OPRX: +110. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HCWC (Consumer Defensive) and XWEL (Consumer Cyclical) and BTMD (Healthcare) and OPRX (Healthcare) and GDRX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCWC is a small-cap high-growth stock; XWEL is a small-cap income-oriented stock; BTMD is a small-cap deep-value stock; OPRX is a small-cap high-growth stock; GDRX is a small-cap quality compounder stock. XWEL, BTMD pay a dividend while HCWC, OPRX, GDRX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.